OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
EHSI.PK57

Elite Health Systems Inc

Healthcare Facilities & ServicesVerified

Elite Health Systems Inc. has a capital structure with no long-term debt and a debt-to-equity ratio of 0.0, indicating a purely equity-funded operation. The company holds $3.76 million in cash and equivalents, which is a significant portion of its total assets of $6.66 million, suggesting strong liquidity in the short term. However, the company reported negative operating cash flow of $2.94 million and free cash flow of $8.81 million, indicating a cash outflow from operations. The current ratio of 3.35 suggests the company has sufficient current assets to cover its current liabilities. In terms of profitability, the company reported a net loss of $7.80 million and an operating loss of $7.82 million, with a return on equity of -146.88% and a return on assets of -117.11%. These figures are significantly below the industry median for profitability metrics, indicating that the company is not currently generating returns for its shareholders or assets. The gross profit of $118,000 is minimal compared to the company's revenue of $1.02 million, suggesting high operating costs or low pricing power. The company's revenue is not segmented by geographic or product lines in the provided data, but the business model is focused on Medicare Advantage plans, which are primarily concentrated in the United States. The company's operations are likely concentrated in the regions where its subsidiaries operate, but specific geographic revenue breakdowns are not disclosed. The company's growth trajectory is not clearly defined in the provided data, but the negative operating and net income suggest that the company is not currently growing profitably. The outlook for the current fiscal year and the next fiscal year is not provided, but the negative financial performance indicates a need for significant operational improvements or revenue growth to achieve profitability. The risk assessment indicates low liquidity and dilution risk, with no immediate filing-based liquidity or dilution flags detected. The company has not issued additional shares recently, and there is no indication of dilution pressure in the near term. The company's financial structure is currently stable, but the negative cash flows and losses suggest that the company may need to raise additional capital in the future to fund operations. Recent events and filings do not indicate any significant changes in the company's operations or financial position. The company is in the early stages of developing its Medicare Advantage business, and there are no recent transcripts or filings that suggest a change in strategy or significant operational progress.

30-day price · EHSI.PK(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyElite Health Systems Inc
TickerEHSI.PK
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Elite Health Systems Inc. operates through its subsidiaries to provide Medicare Advantage plans and related services for seniors and individuals with disabilities or end-stage renal disease.

Classification. The company is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a confidence level of 0.92.

Elite Health Systems Inc. has a capital structure with no long-term debt and a debt-to-equity ratio of 0.0, indicating a purely equity-funded operation. The company holds $3.76 million in cash and equivalents, which is a significant portion of its total assets of $6.66 million, suggesting strong liquidity in the short term. However, the company reported negative operating cash flow of $2.94 million and free cash flow of $8.81 million, indicating a cash outflow from operations. The current ratio of 3.35 suggests the company has sufficient current assets to cover its current liabilities. In terms of profitability, the company reported a net loss of $7.80 million and an operating loss of $7.82 million, with a return on equity of -146.88% and a return on assets of -117.11%. These figures are significantly below the industry median for profitability metrics, indicating that the company is not currently generating returns for its shareholders or assets. The gross profit of $118,000 is minimal compared to the company's revenue of $1.02 million, suggesting high operating costs or low pricing power. The company's revenue is not segmented by geographic or product lines in the provided data, but the business model is focused on Medicare Advantage plans, which are primarily concentrated in the United States. The company's operations are likely concentrated in the regions where its subsidiaries operate, but specific geographic revenue breakdowns are not disclosed. The company's growth trajectory is not clearly defined in the provided data, but the negative operating and net income suggest that the company is not currently growing profitably. The outlook for the current fiscal year and the next fiscal year is not provided, but the negative financial performance indicates a need for significant operational improvements or revenue growth to achieve profitability. The risk assessment indicates low liquidity and dilution risk, with no immediate filing-based liquidity or dilution flags detected. The company has not issued additional shares recently, and there is no indication of dilution pressure in the near term. The company's financial structure is currently stable, but the negative cash flows and losses suggest that the company may need to raise additional capital in the future to fund operations. Recent events and filings do not indicate any significant changes in the company's operations or financial position. The company is in the early stages of developing its Medicare Advantage business, and there are no recent transcripts or filings that suggest a change in strategy or significant operational progress.
Key takeaways
  • Elite Health Systems Inc. is currently operating at a loss with negative returns on equity and assets.
  • The company has no long-term debt and a strong cash position, but negative operating and free cash flows indicate a cash outflow from operations.
  • The company's profitability metrics are significantly below industry medians, suggesting poor operational efficiency.
  • The company's growth trajectory is not clearly defined, and the negative financial performance indicates a need for significant improvements.
  • The company has low liquidity and dilution risk, with no immediate filing-based flags detected.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$1.0M
Gross profit$118.0k
Operating income-$7.8M
Net income-$7.8M
R&D
SG&A
D&A
SBC
Operating cash flow-$2.9M
CapEx-$1.0M
Free cash flow-$8.8M
Total assets$6.7M
Total liabilities$1.4M
Total equity$5.3M
Cash & equivalents$3.8M
Long-term debt$0.00
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$5.3M
Net cash$3.8M
Current ratio3.4
Debt/Equity0.0
ROA-1.2%
ROE-1.5%
Cash conversion38.0%
CapEx/Revenue-99.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Biotechnology · cohort 9 companies
MetricEHSI.PKActivity
Op margin-763.4%11.5% medp25 9.9% · p75 15.0%bottom quartile
Net margin-762.1%8.6% medp25 6.3% · p75 12.4%bottom quartile
Gross margin11.5%28.8% medp25 28.8% · p75 28.8%bottom quartile
CapEx / revenue-99.2%4.2% medp25 3.8% · p75 4.2%bottom quartile
Debt / equity0.0%71.3% medp25 60.7% · p75 71.3%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 23:55 UTC#85e7e3a6
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 11:52 UTCJob: a70cdc36